ziagen solution
viiv healthcare ulc - abacavir (sulfate d'abacavir) - solution - 20mg - abacavir (sulfate d'abacavir) 20mg - nucleoside and nucleotide reverse transcriptase inhibitors
norvir sec capsule
abbvie corporation - ritonavir - capsule - 100mg - ritonavir 100mg - hiv protease inhibitors
norvir solution
abbvie corporation - ritonavir - solution - 80mg - ritonavir 80mg - hiv protease inhibitors
norvir comprimé
abbvie corporation - ritonavir - comprimé - 100mg - ritonavir 100mg - hiv protease inhibitors
norvir capsule
abbvie corporation - ritonavir - capsule - 100mg - ritonavir 100mg - hiv protease inhibitors
triumeq
viiv healthcare b.v. - dolutegravir sodium, lamivudine, abacavir (as sulfate) - infections au vih - antiviraux à usage systémique - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children weighing at least 25 kg who are antiretroviral treatment-naïve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents in triumeq.
trizivir comprimé
viiv healthcare ulc - abacavir (sulfate d'abacavir); lamivudine; zidovudine - comprimé - 300mg; 150mg; 300mg - abacavir (sulfate d'abacavir) 300mg; lamivudine 150mg; zidovudine 300mg - nucleoside and nucleotide reverse transcriptase inhibitors
kivexa comprimé
viiv healthcare ulc - abacavir (sulfate d'abacavir); lamivudine - comprimé - 600mg; 300mg - abacavir (sulfate d'abacavir) 600mg; lamivudine 300mg - nucleoside and nucleotide reverse transcriptase inhibitors
abacavir lamivudin sandoz comprimés pelliculés
sandoz pharmaceuticals ag - abacavirum, lamivudinum - comprimés pelliculés - abacavirum 600 mg ut abacaviri hydrochloridum monohydricum, lamivudinum 300 mg, cellulosum microcristallinum, crospovidonum, povidonum k 30, magnesii stearas, e 172 (flavum), Überzug: hypromellosum, macrogolum 400, polysorbatum 80, e 110 1.415 mg, e 171, pro compresso obducto. - les infections à vih - synthetika
abacavir-lamivudin-mepha 600 mg/300 mg comprimés pelliculés
mepha pharma ag - abacavirum, lamivudinum - comprimés pelliculés - abacavirum 600 mg, lamivudinum 300 mg, cellulosum microcristallinum, hydroxypropylcellulosum, carboxymethylamylum natricum a, magnesii stearas, Überzug: hypromellosum, macrogolum 4000, polysorbatum 80, e 171, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 3.276 mg. - l'infection à vih - synthetika